Advanced Micro Devices’ (AMD) stature has substantially increased over the past several years. The chipmaker has released some great products which have eaten into its traditionally bigger rivals’ dominance. In tandem, the stock has outperformed and left analysts scrambling for the upgrade button. The relentless forward march has continued during the pandemic, too, with shares up by 107% year-to-date. However, one top Wall Street analyst is standing firmly on the sidelines. Northland analyst Gus Richard believes the Street’s CY21 estimates for AMD are simply too high. “We normally model to be in-line with consensus but can't get there in the case of our AMD's CY21 estimates,” the 5-star analyst said.